119 related articles for article (PubMed ID: 34602530)
1. Data on long-term survival of the NOD/Shi-scid IL-2Rγ
Yamashita Y; Sato T; Noishiki K; Kobayashi K; Uchiyama A; Izumi H; Tamura T; Shikamura M; Oinishi Y; Saito M; Kawamata S
J Toxicol Sci; 2021; 46(10):453-469. PubMed ID: 34602530
[TBL] [Abstract][Full Text] [Related]
2. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
3. Background data on NOD/Shi-scid IL-2Rγ
Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
[TBL] [Abstract][Full Text] [Related]
4. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
5. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
[TBL] [Abstract][Full Text] [Related]
6. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg
Nagatani M; Kodera T; Suzuki D; Igura S; Fukunaga Y; Kanemitsu H; Nakamura D; Mochizuki M; Kemi M; Tamura K; Kasahara K
Exp Anim; 2019 Nov; 68(4):471-482. PubMed ID: 31118345
[TBL] [Abstract][Full Text] [Related]
7. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
[TBL] [Abstract][Full Text] [Related]
8. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
9. NOD-Rag2null IL-2Rγnull mice: an alternative to NOG mice for generation of humanized mice.
Katano I; Ito R; Kamisako T; Eto T; Ogura T; Kawai K; Suemizu H; Takahashi T; Kawakami Y; Ito M
Exp Anim; 2014; 63(3):321-30. PubMed ID: 25077762
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouse.
Kato C; Fujii E; Chen YJ; Endaya BB; Matsubara K; Suzuki M; Ohnishi Y; Tamaoki N
Lab Anim; 2009 Oct; 43(4):402-4. PubMed ID: 19505936
[TBL] [Abstract][Full Text] [Related]
11. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
[TBL] [Abstract][Full Text] [Related]
12. Efficient production of immunodeficient non-obese diabetic/Shi-scid
Goto M; Takeo T; Takahashi R; Nakagata N
Lab Anim; 2021 Feb; 55(1):13-20. PubMed ID: 32507045
[TBL] [Abstract][Full Text] [Related]
13. Higher susceptibility of NOG mice to xenotransplanted tumors.
Machida K; Suemizu H; Kawai K; Ishikawa T; Sawada R; Ohnishi Y; Tsuchiya T
J Toxicol Sci; 2009 Feb; 34(1):123-7. PubMed ID: 19182442
[TBL] [Abstract][Full Text] [Related]
14. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
[TBL] [Abstract][Full Text] [Related]
15. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
16. Establishing EGFP congenic mice in a NOD/Shi-scid IL2Rg(null) (NOG) genetic background using a marker-assisted selection protocol (MASP).
Suemizu H; Yagihashi C; Mizushima T; Ogura T; Etoh T; Kawai K; Ito M
Exp Anim; 2008 Oct; 57(5):471-7. PubMed ID: 18946184
[TBL] [Abstract][Full Text] [Related]
17. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
Ito M; Kobayashi K; Nakahata T
Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
[TBL] [Abstract][Full Text] [Related]
18. Characterization of
Kusakawa S; Machida K; Yasuda S; Takada N; Kuroda T; Sawada R; Okura H; Tsutsumi H; Kawamata S; Sato Y
Regen Ther; 2015 Jun; 1():30-37. PubMed ID: 31245439
[TBL] [Abstract][Full Text] [Related]
19. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
20. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
